About
Dr. Nathan Starke is a board-certified urologist and fellowship-trained andrologist practicing in Houston, Texas. He earned his Bachelor of Arts in Neuroscience from Vanderbilt University in 2007, graduating Phi Beta Kappa. He then earned his medical degree from Baylor College of Medicine in 2011, where the Alpha Omega Alpha Honor Medical Society inducted him for academic excellence.
Dr. Starke completed his urology residency at UT Southwestern Medical Center in Dallas. He then pursued advanced fellowship training in andrology at the University of Virginia, one of a small number of accredited programs of its kind in the country. That fellowship focused on male infertility, microsurgery, hormonal health, and sexual medicine. He returned to Houston as the founding Director of the Men's Health Center at Houston Methodist Hospital. He held faculty appointments at Houston Methodist Research Institute, Texas A&M College of Medicine, and Weill Cornell Medical School, training the next generation of urologists. He has authored more than 30 peer-reviewed publications in male reproductive health, sexual medicine, fertility diagnostics, and urologic oncology. He holds membership in the Sexual Medicine Society of North America. Both his parents and all three of his siblings are physicians. He is fluent in English and Spanish. His clinical philosophy centers on grounding treatment decisions in current evidence and explaining options clearly, so patients make genuinely informed choices.
Education & Training
Undergraduate
Vanderbilt University, Bachelor of Arts, Neuroscience, Class of 2007, Phi Beta Kappa
Medical School
Baylor College of Medicine, Medical Degree, Class of 2011, Alpha Omega Alpha Honor Medical Society
Residency
Urology, UT Southwestern Medical Center, Dallas, TX
Fellowship
Andrology (Male Reproductive Medicine & Sexual Health), University of Virginia, Charlottesville, VA
Additional Training
Founding Director, Men's Health Center, Houston Methodist Hospital; Faculty: Houston Methodist Research Institute, Texas A&M College of Medicine, Weill Cornell Medical School
Certifications
Languages
English, Spanish
Conditions Treated
Who is Dr. Starke right for?
Dr. Starke is a strong fit for men dealing with erectile dysfunction, Peyronie's disease, low testosterone, male infertility, or BPH. He also serves women navigating perimenopause, post-menopause, or hormonal imbalance who want individualized hormone therapy. Patients interested in peptide therapy, GLP-1 protocols, or body composition optimization find a highly credentialed guide in Dr. Starke. His fellowship training and research background make him well-suited for complex or previously unresolved cases. Anyone who values direct physician access and evidence-based explanations will feel at home in this practice.
Similar Doctors Nearby
Dr. Gregory BurzynskiMD
Primary Carecardiovascular disease risk, gut microbiome imbalance, insulin resistance +23 more
Dr. Anushree KumarMD
Internal Medicineperimenopause, menopause, premature ovarian insufficiency +4 more
Dr. Shezi KirmaniMD
Internal MedicineFrequently Asked Questions
Dr. Starke treats a wide range of urologic and hormonal conditions. For men, these include erectile dysfunction, Peyronie's disease, hypogonadism, low testosterone, male infertility, varicocele, and BPH. He also screens for urologic cancers. For women, he focuses on perimenopause, post-menopause, and hormonal imbalance. He additionally manages obesity, metabolic syndrome, and sexual dysfunction in both men and women.
Yes. Dr. Starke holds board certification in urology. He also completed a highly specialized andrology fellowship at the University of Virginia, one of a small number of accredited programs of its kind in the United States.
Dr. Starke studied neuroscience at Vanderbilt University and earned his medical degree from Baylor College of Medicine, where Alpha Omega Alpha inducted him for academic distinction. He completed his urology residency at UT Southwestern Medical Center and his andrology fellowship at the University of Virginia.
Dr. Starke performs microsurgical vasectomy reversal, varicocele repair, and penile prosthesis implantation. He also performs microsurgical procedures related to male infertility and sexual medicine. Patients discuss surgical candidacy directly with Dr. Starke during a consultation.
Yes. Dr. Starke treats women with a particular focus on perimenopause, post-menopause, hormone replacement therapy, body composition, and peptide-based optimization. He developed this expertise as a natural extension of his deep background in hormonal health and andrology.
Dr. Starke designs individualized peptide protocols based on each patient's goals and current clinical evidence. He published a detailed peptide therapy reference guide that assigns evidence-level ratings to 41 compounds. He sources compounded medications and peptides through partner licensed 503(a) pharmacies and provides full medical oversight throughout any protocol.
Yes. Dr. Starke is fluent in both English and Spanish. He serves Houston's diverse patient population and conducts full clinical consultations in either language.
Dr. Starke has authored more than 30 peer-reviewed publications. His research covers male reproductive health, sexual medicine, fertility diagnostics, and urologic oncology. He conducted this research during his faculty appointments at Houston Methodist Research Institute, Texas A&M College of Medicine, and Weill Cornell Medical School.
Dr. Starke grounds every treatment decision in current clinical evidence and explains options in plain terms. He wants patients to make genuinely informed choices rather than simply defer to authority. He takes time during each visit to walk through the reasoning behind any recommendation.
Yes. Dr. Starke founded and directed the Men's Health Center at Houston Methodist Hospital. He also held concurrent faculty appointments at Houston Methodist Research Institute, Texas A&M College of Medicine, and Weill Cornell Medical School, where he trained urology residents and maintained an active research program.
Doctor profile last updated August 16, 2026
